EnChroma, Inc. – creators of the EnChroma eyewear for colour blindness – has unveiled the EnChroma® Lx Series for Low Vision and Age-Related Eye Conditions, a new product line to address a growing category of visual challenges worldwide. According to the World Health Organization over 285 million people in the world suffer from severe forms of visual impairment, with approximately 246 million qualifying as low vision. Many visual impairments develop with age with approximately one out of every three adults having some form of vision- reducing eye condition by the age of 65.
Age-related visual impairments such as cataracts, glaucoma and macular degeneration are expected to grow rapidly as a result of aging demographic shifts worldwide. Building on over 10 years of lens expertise from EnChroma’s acclaimed eyewear for colour blindness, the EnChroma Lx Series is designed to support functional vision for people with vision impairments by reducing the disabling effects of glare, improving contrast and enhancing colour vision over multiple lighting conditions. “Until now, the low vision options available to patients have been limited,” said Mark Mattison-Shupnick, Master Optician and Vice President of Business Development for EnChroma. “EnChroma’s new offering for low vision features a unique spectral filter that reduces the intensity of white light while transmitting colors up to two times brighter than an average lens. A patient using the new lens will experience superior glare reduction and comfort, as well as enhanced color and contrast, which can aid mobility and safety.”
To develop the lenses, EnChroma worked with low vision optometrists and patients with rare but serious eye conditions such as retinitis pigmentosa. One of EnChroma’s pre- release testers is Blair Wong, ABOM, BS, M. Ed., Department Chair, Opticianry Department, Benjamin Franklin Institute of Technology, Adjunct Associate Professor, New England College of Optometry, and a licensed optician with late stage retinitis pigmentosa. According to Mr. Wong, “EnChroma augments what little vision I have, that I didn’t think I had. I am able to regain pieces of information I couldn’t perceive before. That enables me to be less reliant on tactile and echo perception.” Patients with conditions such as cataracts, corneal damage, optic neuropathy, macular degeneration, glaucoma and other visual disorders associated with glare sensitivity and reduced colour vision may also benefit from adopting the new lens.